CLINICAL EXPERIENCE OF NEUROLOGICAL
MITOCHONDRIAL DISEASES IN CHILDREN AND ADULTS:
A SINGLE-CENTER STUDY
Rogac M, Neubauer D, Leonardis L, Pecaric N, Meznaric M, Maver A,
Sperl W, Garavaglia BM, Lamantea E, Peterlin B
*Corresponding Author: Mihael Rogac, M.D., Ph.D., Clinical Institute of Genomic Medicine, University
Medical Center Ljubljana, Slajmerjeva 4, 1000 Ljubljana, Slovenia. Tel: +386-1-522-6078. Fax:
+386-1-540-1137. E-mail: mihael.rogac@kclj.si
page: 5
|
|
REFERENCES
1. Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely
EL, Alston CL, et al. Prevalence of nuclear and mitochondrial
DNA mutations related to adult mitochondrial
disease. Ann Neurol. 2015; 77(5): 753-759.
2. Darin N, Oldfors A, Moslemi AR, Holme E, Tulinius
M. The incidence of mitochondrial encephalo-myopathies
in childhood: clinical features and morphological,
biochemical, and DNA abnormalities. Ann
Neurol. 2001; 49(3): 377-383.
3. Raymond FL, Horvath R, Chinnery PF. First-line
genomic diagnosis of mitochondrial disorders. Nat
Rev Genet. 2018; 19(7): 399-400.
4. Picard M, Wallace DC, Burelle Y. The rise of mitochondria
in medicine. Mitochondrion. 2016; 30: 105-116.
5. Wallace DC. Mitochondrial genetic medicine. Nat
Genet. 2018; 50(12): 1642-1649.
6. Morava E, van den Heuvel L, Hol F, de Vries MC,
Hogeveen M, Rodenburg RJ, et al. Mitochondrial
disease criteria: diagnostic applications in children.
Neurology. 2006; 67(10): 1823-1826.
7. Wolf NI, Smeitink JA. Mitochondrial disorders: A
proposal for consensus diagnostic criteria in infants
and children. Neurology. 2002; 59(9): 1402-1405.
8. Witters P, Saada A, Honzik T, Tesarova M, Kleinle S,
Horvath R, et al. Revisiting mitochondrial diagnostic
criteria in the new era of genomics. Genet Med. 2018;
20(4): 444-451.
9. Wortmann SB, Mayr JA, Nuoffer JM, Prokisch H,
Sperl W. A guideline for the diagnosis of pediatric
mitochondrial disease: The value of muscle and skin
biopsies in the genetics era. Neuropediatrics. 2017;
48(4): 309-314.
10. Hui J, Kirby DM, Thorburn DR, Boneh A. Decreased
activities of mitochondrial respiratory chain complexes
in non-mitochondrial respiratory chain diseases.
Dev Med Child Neurol. 2006; 48(2): 132-136.
11. Bugiani M, Invernizzi F, Alberio S, Briem E, Lamantea
E, Carrara F, et al. Clinical and molecular findings
in children with complex I deficiency. Biochim
Biophys Acta. 2004; 1659(2-3): 136-147.
12. Ferriero R, Manco G, Lamantea E, Nusco E, Ferrante
MI, Sordino P, et al. Phenylbutyrate therapy for pyruvate
dehydrogenase complex deficiency and lactic
acidosis. Sci Transl Med. 2013; 5(175): 175ra31.
13. DePristo MA, Banks E, Poplin R, Garimella KV,
Maguire JR, Hartl C, et al. A framework for variation
discovery and genotyping using next-generation DNA
sequencing data. Nat Genet. 2011; 43(5): 491-498.
14. Fouts DE, Pieper R, Szpakowski S, Pohl H, Knoblach
S, Suh MJ, et al. Integrated next-generation sequencing
of 16S rDNA and metaproteomics differentiate
the healthy urine microbiome from asymptomatic
bacteriuria in neuropathic bladder associated with
spinal cord injury. J Transl Med. 2012; 10: 174.
15. Wang K, Li M, Hakonarson H. ANNOVAR: Functional
annotation of genetic variants from high-throughput sequencing
data. Nucleic Acids Res. 2010; 38(16): e164.
16. Liu X, Jian X, Boerwinkle E. dbNSFP v2.0: A database
of human non-synonymous SNVs and their
functional predictions and annotations. Hum Mutat.
2013; 34(9): E2393-E2402. 17. Cingolani P, Platts A, Wang LL, Coon M, Nguyen T,
Wang L, et al. A program for annotating and predicting
the effects of single nucleotide polymorphisms, SnpEff:
SNPs in the genome of Drosophila melanogaster strain
w1118; iso-2; iso-3. Fly (Austin). 2012; 6(2): 80-92.
18. Davydov EV, Goode DL, Sirota M, Cooper GM,
Sidow A, Batzoglou S. Identifying a high fraction of
the human genome to be under selective constraint
using GERP++. PLoS Comput Biol. 2010 ;6(12):
e1001025.
19. Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein
WS, Church DM, et al. ClinVar: public archive of
relationships among sequence variation and human
phenotype. Nucleic Acids Res. 2014; 42(Database
issue): D980-D985.
20. Distelmaier F, Haack TB, Wortmann SB, Mayr JA,
Prokisch H. Treatable mitochondrial diseases: cofactor
metabolism and beyond. Brain. 2017; 140(2): e11.
21. Calvo SE, Clauser KR, Mootha VK. MitoCarta2.0:
An updated inventory of mammalian mitochondrial
proteins. Nucleic Acids Res. 2016; 44(D1): D1251-
D1257.
22. Lieber DS, Calvo SE, Shanahan K, Slate NG, Liu S,
Hershman SG, et al. Targeted exome sequencing of
suspected mitochondrial disorders. Neurology. 2013;
80(19): 1762-1770.
23. Wortmann SB, Koolen DA, Smeitink JA, van den
Heuvel L, Rodenburg RJ. Whole exome sequencing
of suspected mitochondrial patients in clinical
practice. J Inherit Metab Dis. 2015; 38(3): 437-443.
24. Pronicka E, Piekutowska-Abramczuk D, Ciara E,
Trubicka J, Rokicki D, Karkucińska-Wieckowska A,
et al. New perspective in diagnostics of mitochondrial
disorders: Two years’ experience with whole-exome
sequencing at a national paediatric centre. J Transl
Med. 2016; 14(1): 174.
25. Gorman GS, Chinnery PF, DiMauro S, Hirano M,
Koga Y, McFarland R, et al. Mitochondrial diseases.
Nat Rev Dis Primers. 2016; 2: 16080.
26. Belkadi A, Bolze A, Itan Y, Cobat A, Vincent QB,
Antipenko A, et al. Whole-genome sequencing is
more powerful than whole-exome sequencing for
detecting exome variants. Proc Natl Acad Sci U S
A. 2015; 112(17): 5473-5478.
27. Clark MM, Stark Z, Farnaes L, Tan TY, White SM,
Dimmock D, et al. Meta-analysis of the diagnostic and
clinical utility of genome and exome sequencing and
chromosomal microarray in children with suspected
genetic diseases. NPJ Genom Med. 2018; 3: 16.
28. Kingsmore SF, Cakici JA, Clark MM, Gaughran M,
Feddock M, Batalov S, et al. A randomized, controlled
trial of the analytic and diagnostic performance
of singleton and trio, rapid genome and exome
sequencing in ill infants. Am J Hum Genet. 2019;
105(4): 719-733.
29. Calvo SE, Compton AG, Hershman SG, Lim SC,
Lieber DS, Tucker EJ, et al. Molecular diagnosis of
infantile mitochondrial disease with targeted nextgeneration
sequencing. Sci Transl Med. 2012; 4(118):
118ra10.
30. Bricout M, Grévent D, Lebre AS, Rio M, Desguerre
I, De Lonlay P, et al. Brain imaging in mitochondrial
respiratory chain deficiency: Combination of brain
MRI features as a useful tool for genotype/phenotype
correlations. J Med Genet. 2014; 51(7): 429-435.
31. Mascalchi M, Montomoli M, Guerrini R. Neuroimaging
in mitochondrial disorders. Essays Biochem.
2018; 62(3): 409-421.
32. Alves CAPF, Gonçalves FG, Grieb D, Lucato LT,
Goldstein AC, Zuccoli G. Neuroimaging of Mitochondrial
Cytopathies. Top Magn Reson Imaging.
2018; 27(4): 219-240.
33. Lake NJ, Compton AG, Rahman S, Thorburn DR.
Leigh syndrome: One disorder, more than 75 monogenic
causes. Ann Neurol. 2016; 79(2): 190-203.
34. Finsterer J, Höftberger R, Stöllberger C, Rolinski B.
Mimicry between mitochondrial disorder and multiple
sclerosis. Metab Brain Dis. 2012; 27(2): 217-220.
35. van der Knaap MS, Wolf NI, Heine VM. Leukodystrophies:
Five new things. Neurol Clin Pract. 2016;
6(6): 506-514.
36. Niyazov DM, Kahler SG, Frye RE. Primary mitochondrial
disease and secondary mitochondrial dysfunction:
Importance of distinction for diagnosis and
treatment. Mol Syndromol. 2016; 7(3): 122-137.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
